Abstract

Hereditary diffuse gastric cancer (HDGC) is an autosomal-dominant syndrome, accounting for approximately 1% of gastric cancers. The germline pathogenic variant of CDH1, encoding for the tumor-suppressor protein E-cadherin, is implicated in the genetic pathogenesis of HDGC.1Guilford P. Hopkins J. Harraway J. et al.E-cadherin germline mutations in familial gastric cancer.Nature. 1998; 392: 402-405Crossref PubMed Scopus (1318) Google Scholar,2Oliveira C. Pinheiro H. Figueiredo J. et al.Familial gastric cancer: genetic susceptibility, pathology, and implications for management.Lancet Oncol. 2015; 16: e60-e70Abstract Full Text Full Text PDF PubMed Scopus (190) Google Scholar Patients with a pathogenic variant of CDH1 are recommended to undergo a prophylactic gastrectomy owing to a high cumulative risk of diffuse-type gastric cancer over the age of 80 years: 70% for men and 56% for women.3Hansford S. Kaurah P. Li-Chang H. et al.Hereditary diffuse gastric cancer syndrome.JAMA Oncol. 2015; 1: 23-32Crossref PubMed Scopus (349) Google Scholar,4Van der Post R.S. Vogelaar I.P. Carneiro F. et al.Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.J Med Genet. 2015; 52: 361-374Crossref PubMed Scopus (329) Google Scholar Thus, it is important to identify this hereditary cancer syndrome to provide an appropriate treatment. For some patients with the pathogenic variant of that gene who decline to undergo prophylactic gastrectomy, histologic assessment of the presence of microscopic foci of intramucosal signet-ring cell carcinoma (SRCC) and its precursor lesions (which are characteristic of early HDGC)5Charlton A. Blair V. Shaw D. et al.Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone.Gut. 2004; 53: 814-820Crossref PubMed Scopus (138) Google Scholar,6Tsugeno Y. Nakano K. Nakajima T. et al.Histopathologic analysis of signet-ring cell carcinoma in situ in patients with hereditary diffuse gastric cancer.Am J Surg Pathol. 2020; 44: 1204-1212Crossref PubMed Scopus (4) Google Scholar could be a helpful factor during the decision-making process. Owing to the difficulty of detecting the tiny SRCC foci endoscopically, collecting at least 30 random endoscopic biopsy specimens is recommended in the Cambridge protocol.7Fitzgerald R.C. Hardwick R. Huntsman D. et al.Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research.J Med Genet. 2010; 47: 436-444Crossref PubMed Scopus (404) Google Scholar In contrast, some studies have reported that targeted biopsies or a combination of targeted and random biopsies might increase diagnostic accuracy.8Shaw D. Blair V. Framp A. et al.Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy?.Gut. 2005; 54: 461-468Crossref PubMed Scopus (136) Google Scholar,9Mi E.Z. Mi E.Z. di Pietro M. et al.Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status.Gastrointest Endosc. 2018; 87: 408-418Abstract Full Text Full Text PDF PubMed Scopus (51) Google Scholar However, the usefulness of that approach is controversial.10Huneburg R. Marwitz T. van Heteren P. et al.Chromoendoscopy in combination with random biopsies does not improve detection of gastric cancer foci in CDH1 mutation positive patients.Endosc Int Open. 2016; 4: E1305-E1310Crossref PubMed Google Scholar To improve the diagnostic performance for early HDGC lesions, it is essential to describe the characteristic endoscopic features of those tumors. In this video report, we detected multiple SRCC foci in preoperative EGD for endoscopic submucosal dissection, which led to the successful diagnosis of HDGC with a CDH1 mutation. We introduce a video (Video 1, available online at www.giejournal.org) showing multiple lesions of early HDGC in white-light imaging, narrow-band imaging (NBI), and magnifying endoscopy with NBI. This study was conducted according to the Helsinki Declaration of the World Medical Association and was approved by the Institutional Review Board of the Cancer Institute Hospital of the Japanese Foundation for Cancer Research (approval number 2020–1158). A 34-year-old man with a family history of gastric cancer underwent EGD in another hospital to assess the cause of discomfort in his throat. There, he was histologically diagnosed with an early diffuse-type gastric cancer (DGC). He was referred to our institution for further investigation by EGD. He was intended to undergo endoscopic submucosal dissection for DGC, which was suspected to be a sporadic cancer. He had no history of Helicobacter pylori infection or eradication therapy. EGD in our institution revealed 6 more pale lesions under white-light imaging with slightly irregular microvessels and/or microsurface structures under magnifying endoscopy with NBI, suggesting cancerous lesions (Figure 1, Figure 2, Figure 3, Figure 4; Video 1, available online at www.VideoGIE.org). We conducted a targeted biopsy for 4 highly suspicious lesions, and SRCC foci were detected histologically in 2 of 4 lesions (Figure 3, Figure 4, Figure 5). Considering the clinical and endoscopic findings, genetic counseling and germline CDH1 genetic testing were performed for this patient, which revealed the presence of the CDH1 pathogenic variant (c.603del, p.Val202Leufs∗13).Figure 2Magnifying endoscopy with narrow-band imaging revealed unclear surface structures and irregular microvessels.View Large Image Figure ViewerDownload Hi-res image Download (PPT)Figure 3A, White-light imaging revealed a flat and slightly pale lesion at the greater curvature of the gastric antrum, located distal side of the main lesion (Fig. 1). B, The pale mucosa was visualized more clearly as a whitish lesion under narrow-band imaging.View Large Image Figure ViewerDownload Hi-res image Download (PPT)Figure 4Magnifying endoscopy with narrow-band imaging of the area in the yellow square frame in Figure 3A and B (marginal area of distal side of the lesion) revealed unclear surface structures and irregular microvessels (arrow).View Large Image Figure ViewerDownload Hi-res image Download (PPT)Figure 5A, Biopsy specimen from the lesion in Figures 3 and 4 histologically revealed signet-ring cell carcinoma distributed from the middle to the superficial layer of the mucosa (hematoxylin and eosin staining, low-power magnification, scale bar = 50 μm). B, Signet-ring cell carcinoma in Figure 5A composed of mucin-rich cytoplasm and crescent-shaped hyperchromatic nuclei (hematoxylin and eosin staining, high-power magnification, scale bar = 20 μm).View Large Image Figure ViewerDownload Hi-res image Download (PPT) The patient underwent total gastrectomy with lymph node dissection. Histopathologic analysis of the entire resected specimen, which had been cut into 400 blocks, revealed the presence of 42 intramucosal SRCCs without any component of poorly differentiated adenocarcinoma, including 26 intramucosal invasive carcinomas (pT1a) and 16 noninvasive carcinomas (SRCC in situ, pTis) (Fig. 6). No lymph node metastasis was found. The final pathologic staging of the tumor was pT1aN0M0. The authors thank Dr Shoichi Yoshimizu (Department of Gastroenterology, Cancer Institute Hospital, Japanese Foundation for Cancer Japanese Foundation for Cancer Research) and Soya Nunobe (Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Japanese Foundation for Cancer Research) for advice on this article. All authors disclosed no financial relationships. https://www.videogie.org/cms/asset/c2e276be-3b24-4d31-97fe-3ac88ce09b6f/mmc1.mp4Loading ... Download .mp4 (128.57 MB) Help with .mp4 files Video 1This is a video of esophagogastroduodenoscopy preoperatively performed for endoscopic submucosal dissection. This video showed multiple signet-ring cell carcinoma foci under white-light imaging and magnifying narrow-band imaging, which were diagnosed by targeted biopsy. The patient was diagnosed as hereditary diffuse gastric cancer with CDH1 mutation.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call